UY27429A1 - MEDICINAL PRODUCT FOR THERAPEUTIC OR PREVENTIVE TREATMENT OF TUBERCULOSIS THAT INCLUDES AN Erythromycin Derivative - Google Patents

MEDICINAL PRODUCT FOR THERAPEUTIC OR PREVENTIVE TREATMENT OF TUBERCULOSIS THAT INCLUDES AN Erythromycin Derivative

Info

Publication number
UY27429A1
UY27429A1 UY27429A UY27429A UY27429A1 UY 27429 A1 UY27429 A1 UY 27429A1 UY 27429 A UY27429 A UY 27429A UY 27429 A UY27429 A UY 27429A UY 27429 A1 UY27429 A1 UY 27429A1
Authority
UY
Uruguay
Prior art keywords
tuberculosis
therapeutic
substituted
erythromycin derivative
memory
Prior art date
Application number
UY27429A
Other languages
Spanish (es)
Inventor
Yoshida Toshihiko
Takahashi Yoshie
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of UY27429A1 publication Critical patent/UY27429A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Abstract

Medicamento para tratar y/o prevenir la tuberculosis que comprende un derivado de eritromicina de fórmula (I) y una sal, hidrato y un solvato farmacéuticamente aceptables del mismo, en donde R representa hidrógeno, y otros según la memoria; R1 representa alquilo de C5-12 que puede ser sustituido, y otros según la memoria; R2 representa hidrógeno o un grupo carbamoilo que puede ser sustituido; R3 representa un grupo acilo que puede ser sustituido, y otros segun la memoria; R4 representa un grupo alquilo que puede ser sustituido, y otros según la memoria. Uso de dicho compuesto para fabricar dicho medicamento.Medication for treating and / or preventing tuberculosis comprising an erythromycin derivative of formula (I) and a pharmaceutically acceptable salt, hydrate and solvate thereof, wherein R represents hydrogen, and others according to memory; R1 represents C5-12 alkyl that can be substituted, and others according to memory; R2 represents hydrogen or a carbamoyl group that can be substituted; R3 represents an acyl group that can be substituted, and others according to memory; R4 represents an alkyl group that can be substituted, and others according to memory. Use of said compound to manufacture said medicament.

UY27429A 2001-09-05 2002-09-03 MEDICINAL PRODUCT FOR THERAPEUTIC OR PREVENTIVE TREATMENT OF TUBERCULOSIS THAT INCLUDES AN Erythromycin Derivative UY27429A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001268213 2001-09-05

Publications (1)

Publication Number Publication Date
UY27429A1 true UY27429A1 (en) 2003-10-31

Family

ID=19094233

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27429A UY27429A1 (en) 2001-09-05 2002-09-03 MEDICINAL PRODUCT FOR THERAPEUTIC OR PREVENTIVE TREATMENT OF TUBERCULOSIS THAT INCLUDES AN Erythromycin Derivative

Country Status (4)

Country Link
AR (1) AR036587A1 (en)
PE (1) PE20030438A1 (en)
UY (1) UY27429A1 (en)
WO (1) WO2003022289A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212682A1 (en) * 1995-02-10 1996-08-15 Worcester Foundation For Experimental Biology, Inc. Delivery of exogenous compounds
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
ID30233A (en) * 1999-01-27 2001-11-15 Pfizer Prod Inc ANTIBIOTICS OF TETOLIDA
AR023264A1 (en) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical ERYTHROMYCIN DERIVATIVES
EP1122261A3 (en) * 2000-01-31 2001-09-26 Pfizer Products Inc. 13 and 14-membered antibacterial macrolides

Also Published As

Publication number Publication date
WO2003022289A1 (en) 2003-03-20
AR036587A1 (en) 2004-09-22
PE20030438A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
AR035482A1 (en) USE OF A CYANOQUINOLINE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR INHIBIT COLONY POLYPS
IT1271495B (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
GEP20043324B (en) Purine Derivatives
AR029174A1 (en) DERIVATIVES OF ESPIROOXINDOL, PROCESS FOR PREPARATION, PHARMACEUTICAL FORMULATION, AND USE OF DERIVATIVES IN THE MANUFACTURE OF MEDICINES
ES2295609T3 (en) TIADIAZOLILPIPERAZINA DERIVATIVES USEFUL TO TREAT OR PREVENT A PAIN.
NO20060974L (en) Pyridazine derivatives and their use as therapeutic agents
NO20062905L (en) Novel hydroxamic acid esters and their pharmaceutical use
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
HN2004000232A (en) "PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM."
UY27533A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING OXIBUTININE
BRPI0418026A (en) phenylalanine derivatives or pharmaceutically acceptable salts thereof, pharmaceutical composition, alpha4 integrin antagonist, and therapeutic or preventative agent for diseases
UY29085A1 (en) PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
RU2008119454A (en) MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS
SE9901573D0 (en) New compounds
DE60143911D1 (en) ANTITUMOR COMPOSITIONS CONTAINING ECTEINASCIDINE 743
AR030039A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A SELECTIVE INHIBITOR DRUG OF CYCLOOXYGENASA-2, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR PREVENT AFFECTIONS THROUGH CYCLOOXYGENASE-2 AND METHOD TO MAKE SUCH MEDICINAL PRODUCT
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
FR2850023B1 (en) DRUGS FOR THE NERVOUS SYSTEM
SE0002476D0 (en) New compounds
ES2196167T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING PROPIONATE 3- (2,2,2-TRIMETHYL HYDRAZINY) AND GAMMA-BUTIROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
NO20054360L (en) New oxazole derivatives, their preparation and use as pharmaceutical preparations
HUP0300863A2 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide, process for producing it and pharmaceutical composition containing it
AR029666A1 (en) USE OF (+) -ALFA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINMETHANOL OR ITS DRUG FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND OF PSYCHOSIS INDUCED BY DOPAMINE
SE9901572D0 (en) New compounds

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20101118